Event dossier

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug GSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels,…

0 reports0 sourcesApr 12, 2026, 3:02 PM
FilterEvent feed
Clustered coverageAll sources
Coverage timeline0
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

No linked coverage has been stored for this event yet.
Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.